US 8609728
Treatment for pulmonary hypertension
granted A61KA61K31/513A61K31/522
Quick answer
US patent 8609728 (Treatment for pulmonary hypertension) held by United Therapeutics Corporation expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/513, A61K31/522, A61K31/557, A61K31/5575